{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:37:24Z","timestamp":1792460244505,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.ejphar.2024.176770","type":"journal-article","created":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T12:02:39Z","timestamp":1719230559000},"page":"176770","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Forskolin is an effective therapeutic small molecule for the treatment of hypertrophic cardiomyopathy through ADCY6\/cAMP\/PKA pathway"],"prefix":"10.1016","volume":"978","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-7992-8125","authenticated-orcid":false,"given":"Wenyan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5879-8955","authenticated-orcid":false,"given":"Yingying","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dujuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenwen","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kejia","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2024.176770_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.870699","article-title":"Liquiritin Attenuates pathological cardiac hypertrophy by activating the PKA\/LKB1\/AMPK pathway","volume":"13","author":"Aiyasiding","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.176770_bib2","first-page":"5","article-title":"Forskolin and derivatives as tools for studying the role of cAMP","volume":"671","author":"Alasbahi","year":"2012","journal-title":"Die Pharmazie-An International Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.ejphar.2024.176770_bib3","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/ejhf.541","article-title":"Pharmacological treatment of hypertrophic cardiomyopathy: current practice and novel perspectives","volume":"189","author":"Ammirati","year":"2016","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ejphar.2024.176770_bib4","first-page":"26","article-title":"Outcomes in patients with hypertrophic cardiomyopathy awaiting heart transplantation","volume":"113","author":"Cisneros","year":"2018","journal-title":"Circ.-Heart Fail."},{"key":"10.1016\/j.ejphar.2024.176770_bib5","doi-asserted-by":"crossref","first-page":"22272","DOI":"10.1074\/jbc.272.35.22272","article-title":"Interactions of forskolin and ATP with the cytosolic domains of mammalian adenylyl cyclase","volume":"27235","author":"Dessauer","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2024.176770_bib6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1124\/pr.116.013078","article-title":"International union of basic and clinical pharmacology. CI. Structures and small molecule modulators of mammalian adenylyl cyclases","volume":"692","author":"Dessauer","year":"2017","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2024.176770_bib7","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.cellsig.2015.10.003","article-title":"Sustained exposure to catecholamines affects cAMP\/PKA compartmentalised signalling in adult rat ventricular myocytes","volume":"287","author":"Fields","year":"2016","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ejphar.2024.176770_bib8","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1161\/01.CIR.38.5.846","article-title":"Muscular subaortic stenosis. Prevention of outflow obstruction with propranolol","volume":"385","author":"Flamm","year":"1968","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2024.176770_bib9","first-page":"17","article-title":"Regulation of cardiac function by cAMP nanodomains","volume":"432","author":"Folkmanaite","year":"2023","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.ejphar.2024.176770_bib10","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.biopha.2018.01.080","article-title":"Forskolin protects against cisplatin-induced ototoxicity by inhibiting apoptosis and ROS production","volume":"99","author":"Guo","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2024.176770_bib11","doi-asserted-by":"crossref","first-page":"9638","DOI":"10.1111\/jcmm.15476","article-title":"The cyclic adenosine monophosphate elevating medicine, forskolin, reduces neointimal formation and atherogenesis in mice","volume":"2417","author":"Hao","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.ejphar.2024.176770_bib12","doi-asserted-by":"crossref","first-page":"9638","DOI":"10.1111\/jcmm.15476","article-title":"The cyclic adenosine monophosphate elevating medicine, forskolin, reduces neointimal formation and atherogenesis in mice","volume":"2417","author":"Hao","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.ejphar.2024.176770_bib13","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1177\/147323001003800229","article-title":"Forskolin compared with beclomethasone for prevention of asthma attacks: a single-blind clinical trial","volume":"382","author":"Huerta","year":"2010","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.ejphar.2024.176770_bib14","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1161\/01.CIR.0000136033.21777.4D","article-title":"Intracoronary adenovirus encoding adenylyl cyclase VI increases left ventricular function in heart failure","volume":"1103","author":"Lai","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2024.176770_bib15","first-page":"619","article-title":"Inhibition of fatty acid oxidation enables heart regeneration in adult mice","volume":"6227983","author":"Li","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2024.176770_bib16","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1093\/cvr\/cvab008","article-title":"Physiological and pathological roles of protein kinase A in the heart","volume":"1182","author":"Liu","year":"2022","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2024.176770_bib17","doi-asserted-by":"crossref","first-page":"9508","DOI":"10.3390\/nu7115483","article-title":"Coleus forskohlii extract supplementation in conjunction with a hypocaloric diet reduces the risk factors of metabolic syndrome in overweight and obese subjects: a randomized controlled trial","volume":"711","author":"Loftus","year":"2015","journal-title":"Nutrients"},{"key":"10.1016\/j.ejphar.2024.176770_bib18","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.sjopt.2015.02.003","article-title":"Efficacy and safety of 1% forskolin eye drops in open angle glaucoma - an open label study","volume":"293","author":"Majeed","year":"2015","journal-title":"Saudi J Ophthalmol"},{"key":"10.1016\/j.ejphar.2024.176770_bib19","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1161\/CIRCRESAHA.121.318346","article-title":"Molecular genetic basis of hypertrophic cardiomyopathy","volume":"12810","author":"Marian","year":"2021","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2024.176770_bib20","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1161\/CIRCULATIONAHA.107.698662","article-title":"Disruption of type 5 adenylyl cyclase enhances desensitization of cyclic adenosine monophosphate signal and increases akt signal with chronic catecholamine stress","volume":"11616","author":"Okumura","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2024.176770_bib21","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1152\/physrev.00013.2021","article-title":"Physiological roles of mammalian transmembrane adenylyl cyclase isoforms","volume":"1022","author":"Ostrom","year":"2022","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejphar.2024.176770_bib22","first-page":"13","article-title":"The therapeutic potential of the labdane diterpenoid forskolin","volume":"919","author":"Salehi","year":"2019","journal-title":"Appl. Sci.-Basel"},{"key":"10.1016\/j.ejphar.2024.176770_bib23","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1073\/pnas.78.6.3363","article-title":"Forskolin: unique diterpene activator of adenylate cyclase in membranes and in intact cells","volume":"786","author":"Seamon","year":"1981","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.ejphar.2024.176770_bib24","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jacc.2015.01.019","article-title":"New perspectives on the prevalence of hypertrophic cardiomyopathy","volume":"6512","author":"Semsarian","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2024.176770_bib25","first-page":"39","article-title":"Treatment of glaucoma with natural products and their mechanism of action: an update","volume":"143","author":"Sim","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.ejphar.2024.176770_bib26","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/eurheartj\/ehs150","article-title":"Pharmacological treatment options for hypertrophic cardiomyopathy: high time for evidence","volume":"3314","author":"Spoladore","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejphar.2024.176770_bib27","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1161\/CIRCULATIONAHA.106.632513","article-title":"Increased cardiac adenylyl cyclase expression is associated with increased survival after myocardial infarction","volume":"1145","author":"Takahashi","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2024.176770_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.103878","article-title":"Recent discoveries of the role of histone modifications and related inhibitors in pathological cardiac hypertrophy","author":"Wu","year":"2024","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejphar.2024.176770_bib29","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/cvr\/cvt264","article-title":"Inhibition of DNA methylation reverses norepinephrine-induced cardiac hypertrophy in rats","volume":"1013","author":"Xiao","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2024.176770_bib30","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.yjmcc.2013.11.001","article-title":"PKA catalytic subunit compartmentation regulates contractile and hypertrophic responses to \u03b2-adrenergic signaling","volume":"66","author":"Yang","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ejphar.2024.176770_bib31","article-title":"Allosteric activation of transglutaminase 2 via inducing an \"open\" conformation for osteoblast differentiation","volume":"1018","author":"Yang","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ejphar.2024.176770_bib32","article-title":"Forskolin protected against streptozotocin-induced diabetic cardiomyopathy via inhibition of oxidative stress and cardiac fibrosis in mice","volume":"8","author":"Zhang","year":"2021","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.ejphar.2024.176770_bib33","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1161\/CIRCRESAHA.114.305892","article-title":"Cardiac hypertrophy is inhibited by a local pool of cAMP regulated by phosphodiesterase 2","volume":"1178","author":"Zoccarato","year":"2015","journal-title":"Circ. Res."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924004588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924004588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T16:12:00Z","timestamp":1721664720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299924004588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":33,"alternative-id":["S0014299924004588"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.176770","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Forskolin is an effective therapeutic small molecule for the treatment of hypertrophic cardiomyopathy through ADCY6\/cAMP\/PKA pathway","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.176770","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"176770"}}